— Know what they know.
Not Investment Advice
Asset Manager ← All Institutions

Pivotal bioVenture Partners Investment Advisor LLC

Q3 2025 · Filed 2025-11-13
Market Value
$131M
+13.3%
Holdings
11
+1
New Purchases
1
Added To
2
Closed
3
Reduced
0
Top 10 Concentration
100.0%
Turnover
36.4%

Top Buys (by % of Portfolio)

SymbolCur %Prior %Chg %Value
ZBIO 13.17% 6.51% +6.65% $17M
ARQT 30.43% 25.66% +4.78% $40M
IMNM 4.48% 0.00% +4.48% $6M
TRVI 8.76% 5.41% +3.35% $11M
PCVX 37.64% 36.62% +1.02% $49M
BIOA 2.93% 2.33% +0.60% $4M

Top Sells (by % of Portfolio)

SymbolCur %Prior %Chg %Value
INZY 0.00% 15.52% -15.52% $0
VIGL 0.00% 3.85% -3.85% $0
IOBT 0.00% 1.04% -1.04% $0
RXRX 2.21% 2.60% -0.39% $3M
BOLT 0.38% 0.47% -0.09% $503K

Sector Allocation Over Time

Market Cap Concentration

TierHoldingsValueWeight
Mid Cap 3 $92M 70.3%
Small Cap 4 $35M 26.4%
Micro Cap 4 $4M 3.3%

Portfolio Analytics

Avg Market Cap
$1.8B
Median Market Cap
$1.8B
Avg P/E
113.9
Median P/E
113.9
Avg Dividend Yield
—%
Avg Beta
1.32
# Stocks
11
# ETFs / Funds
0

Top Holdings (11 total)

# Symbol % Port Shares Value Avg Price Q/Q Value Chg Share Chg Chg % Status
1 PCVX 37.64% 1,372,425 $49M $36.02 $7M +67,300 +5.2%
2 ARQT 30.43% 2,120,508 $40M $18.85 $10M — —
3 ZBIO 13.17% 779,045 $17M $22.20 $10M — —
4 TRVI 8.76% 1,256,782 $11M $9.15 $5M +110,672 +9.7%
5 IMNM 4.48% 502,512 $6M $11.71 — +502,512 — NEW
6 BIOA 2.93% 653,374 $4M $5.88 $1M — —
7 RXRX 2.21% 595,518 $3M $4.88 -$107K — —
8 BOLT 0.38% 94,573 $503K $5.32 -$43K — —
9 INZY —% — — — -$18M -4,494,851 -100.0% SOLD
10 IOBT —% — — — -$1M -864,197 -100.0% SOLD
11 VIGL —% — — — -$4M -560,595 -100.0% SOLD

New Positions

SymbolValue% Port
IMNM $6M 4.48%

Sold Out Positions

SymbolValue% Port
INZY — —%
IOBT — —%
VIGL — —%
View SEC EDGAR Filings for Pivotal bioVenture Partners Investment Advisor LLC →

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms